Fundraising FoxIntermediate Capital Group — Full Portfolio
7 tracked investments · listed companies and verified rows first
Eliem Therapeutics is a clinical-stage biotechnology company developing monoclonal antibodies targeting immune-mediated diseases, with budoprutug, an anti-CD19 antibody designed to deplete B cells in conditions including primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL antibody for IgA nephropathy and related B-cell mediated diseases.
BiotechWilmington, US
Valerie Morisset(Executive Officer)inErin Lavelle(Executive Officer)inRobert Azelby(Executive Officer, Director)James Bucher(Executive Officer)Leone Patterson(Director)
BoardAdam Rosenberg(Director)
Co-investorsManta Ray VenturesAccess BiotechnologyACORN BIOVENTURESLifeArc VenturesRA Capital
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtechSan Carlos, US
Anthony Ford(Executive Officer, Director)inBenjamin Potter(Executive Officer)Henry Skinner(Director)Liam Ratcliffe(Director)in
BoardRon Hunt(Director)inLoretta Tse, Ph.D.(Director)
Co-investorsAlta PartnersLongitude Capitalabrdn plcJohnson & Johnson Innovation – JJDCNew Leaf Venture PartnersPappas Capital+2 more
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Co-investorsAndera PartnersATEM Capital FundCTI Life Sciences Fund L.P.EQT Life SciencesKurma PartnersOctalfa+4 more
Enfinity provides renewable energy services, developing and operating solar, wind, and storage projects to supply corporate, industrial, and institutional clients with continuous power.
CleantechClimate TechEnergy
Co-investorsEiffel Investment Group
Kee Safety designs, manufactures, and supplies fall protection and working-at-height safety systems, including guardrails, rigid rail systems, and related equipment, along with consulting and assessment services.
Advanced ManufacturingHardware
Co-investorsInflexion65 Equity Partners Pte. Ltd.Investcorp
Van Geloven is a Dutch snacks manufacturer with multiple brand portfolios including Mora, Van Dobben, and others, serving food service and retail channels.
Advanced ManufacturingFoodTech
Co-investorsTowerBrook
Allotera (formerly Wugen) develops allogeneic T-cell therapies.
BiotechHealthtechMedical DevicesSt. Louis, US
Ayman Kabakibi(Executive Officer)inCherry Thomas(Executive Officer)inKumar Srinivasan(Executive Officer, Director)inKeith Vendola(Executive Officer)Daniel M Kemp(Executive Officer, Director)Matthew Cooper(Executive Officer)
Co-investorsAisling CapitalAlpha Wave GlobalBioGenerator VenturesRiverVest Venture PartnersAbingworthFidelity Investments+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.